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The caspase recruitment domain (CARD)-containing proteins CARMA1-3 share high degree of sequence, structure and functional
homology. Whereas CARMA1 and CARMA3 have been identiﬁed as crucial components of signal transduction pathways that lead to
activation of NF-kB transcription factor, little is known about the function of CARMA2. Here we report the identiﬁcation of two splice
variants of CARMA2. One transcript, named CARMA2short (CARMA2sh),is predicted to encodefor a CARMA2 polypeptidecontaining
theCARD,coiledcoil,andaPDZdomains,butlackingtheSH3andtheGuKdomains.Thesecondvariant,CARMA2cardless(CARMA2cl),
encodesforapolypeptidelackingtheCARDdomainandcontainingonlyaportionofthecoiledcoildomainandalinkerregion.Expression
analysis conﬁrmed the presence of the CARMA2 alternatively spliced transcripts in both human cell lines and tissues. Fluorescence
microscopy data show that both splice variants localize in the cytosol. Biochemical experiments indicate that CARMA2sh interacts with
TRAF2andactivatesNF-kBinaTRAF2-dependentmanner.Finally,CARMA2shvariantprotectscellsfromapoptosisinducedbydifferent
stimuli.Takentogether,theseresultsdemonstratethatmultipletranscriptsencodingseveralCARMA2isoformsexistinvivoandregulate
NF-kB activation and apoptosis.
J. Cell. Physiol. 226: 3121–3131, 2011.  2011 Wiley Periodicals, Inc.
The caspase recruitment domain (CARD)-containing proteins
CARMA1 (CARD11/Bimp2) (Bertin et al., 2001; Gaide et al.,
2001; Wang et al., 2001), CARMA2 (CARD14/Bimp3) (Bertin
et al., 2001), and CARMA3 (CARD10/Bimp1) (Wang et al.,
2001; McAllister-Lucas et al., 2001) share a high degree of
sequence, structure, and functional homology. CARMA
proteins belong to the membrane-associated guanylate kinase
(MAGUK) family of proteins, which can function as molecular
scaffolds that assist recruitment and assembly of signal
transduction molecules (Dimitratos et al., 1999). CARMA
proteins contain a CARD domain, a Src-homology 3 (SH3)
domain,oneorseveralPDZdomainsandaGuKdomain(Bertin
et al., 2001; Gaide et al., 2001; Wang et al., 2001; McAllister-
Lucas et al., 2001). Genetic and biochemical studies have
identiﬁed CARMA1 as crucial component of a complex of
proteinsthatlinksantigenreceptorsonBandTlymphocytesto
activation of NF-kB (Wang et al., 2002; Gaide et al., 2002;
Pomerantz et al., 2002; Hara et al., 2003; Egawa et al., 2003;
Newton and Dixit, 2003; Jun et al., 2003). This complex, which
includes CARMA1, BCL10, MALT1, and TRAF6, has been
shown to activate the IKK complex through an ubiquitylation-
dependent pathway (Schulze-Luehrmann and Ghosh, 2006).
A second member of the CARMA family, CARMA3, is
requiredforactivationofNF-kBinducedbyG-protein-coupled
receptors (GPCRs) (Grabiner et al., 2007; McAllister-Lucas
etal.,2007).Infact,ithasbeendemonstratedthatacomplexof
proteins, including CARMA3, BCL10, and MALT1, appears to
be responsible for transmitting the signal from the GPCRs to
the IKK complex (Grabiner et al., 2007; McAllister-Lucas et al.,
2007). By contrast, although overexpression of CARMA2 also
induces NF-kB activation in HEK-293 cells (Bertin et al., 2001),
the signaling pathway(s) regulated by this protein is still
unknown. Here we describe the identiﬁcation of two splice
variantsofCARMA2andshowdataindicatinganinvolvementof
these proteins in regulation of NF-kB activation and
endoplasmic reticulum (ER)-stress induced cell death.
Results
Previous work identiﬁed CARMA2/CARD14 (CARMA2FL) as
a 1,004 aminoacidic residues protein belongingtothe CARMA
family of proteins (Bertin et al., 2001). To examine the
occurrence of splice variants derived from the human CARMA2
gene, we performed an extensive reverse transcription-
polymerase chain reaction (RT-PCR) analysis of mRNAs
isolated from human cell lines using CARMA2/CARD14
exon-speciﬁc primers.
Such analysis revealed the existence of two different splice
variants of CARMA2/CARD14. One variant contains the same
translational start of CARMA2FL but includes an additional
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 2011 WILEY PERIODICALS, INC.exon (alternative exon 15) containing an alternative stop codon.
This transcript is predicted to encode for a polypeptide
corresponding to amino acids 1–740 of CARMA2FL, and
therefore we named this variant CARMA2short (CARMA2sh)
(Fig. 1A,B). The second variant mRNA skips exons 1–4,
contains an alternative translational start codon in exon 5 and
includesanadditionalexoncontaininganalternativestopcodon
(Fig. 1A,B). The CARMA2isoform encodedby thissplice variant
Fig. 1. CARMA2 isoforms. A: Amino acid alignment of CARMA2FL, CARMA2sh, and CARMA2cl. The unique sequence of CARMA2clis in bold.
B: Schematic representation ofCARMA2FL, CARMA2sh,andCARMA2clisoforms. [Color ﬁgurecanbe seenin theonlineversion ofthisarticle,
available at http://wileyonlinelibrary.com/journal/jcp]
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238-
Val
618 of CARMA2FL and contains a unique carboxy terminus
(Fig. 1A,B). We named this variant CARMA2cardless
(CARMA2cl).
To conﬁrm the existence of these alternatively spliced
transcripts of CARMA2, we performed RT-PCR on mRNAs
isolatedfromdifferenthumannormalandtumoralcelllinesand
normaltissuesusinginternalprimersthatcandistinguisheachof
the splice variants. Using a primer set speciﬁc for exon 15 and
the alternative exon 15, we detected a PCR product that
corresponds to the predicted size of a fragment derived from
transcripts encoding CARMA2sh (Fig. 2A). This transcript was
expressed in most of the cell lines tested, in human fetal brain
and human leucocytes (Fig. 2A).
We also conﬁrmed the presence of the transcript
codingforCARMA2clusingaprimerwithinthe50-untranslated
region paired with a reverse primer located in exon 5. The
CARMA2cl transcript was expressed only in HeLa cells
(Fig. 2A).
To study these CARMA2 splice variants, we generated a
polyclonal rabbit antibody directed against a polypeptide
corresponding to aa 108–407 of CARMA2 FL (Fig. 2B). When
probed on cell lysates prepared from HeLa and HEK-293 cells,
the antisera detected bands corresponding to the predicted
size of endogenous CARMA2FL, CARMA2sh, and CARMA2cl
isoforms. The antisera also recognizes additional bands,
indicating that other splice variants of CARMA2 may occur
(Fig. 2C).
Fig. 2. CARMA2isoformexpression.A:RT-PCRwasusedtoanalyzeCARMA2transcriptsinapartofcDNAfromvarioushumantissuesandcell
lines. These comprised human lung carcinoma (NCI-H226, DMS-79, CALU1, NCI-H526, SHP77, A549, NCI-H460, NCI-H1975, NCI-H292, and
NCI-H2009)mesothelioma(NCI-H28)normalepithelial(SAEC,NHBE),Burkitt’slimphoma(Raji),coloncarcinoma(HT29),monociticleukemia
(THP1), bronchial carcinoma (BEN), T cell leukemia (Jurkat), and cervical carcinoma (HeLa). Where indicated, cells were stimulated with
tumor necrosis factor a (TNFa) or thiazolidinedione (TZD) before RNA extraction. Identity of amplicons was conﬁrmed by DNA
sequencing. B: Speciﬁcity of the antiserum to CARMA2 used in this study. HEK-293 cells were transfected with a vector that was empty or
expressing FLAG-tagged CARMA2sh. Twenty-four hours later, cell lysates were separated by SDS–PAGE and transferred onto membranes
subsequently probed with anti-FLAG mAb, afﬁnity-puriﬁed anti-CARMA2 rabbit antiserum or preimmune rabbit serum, as indicated.
C:CelllysateswerepreparedfromHeLaandHEK-293cells,separatedbySDS–PAGE,andtransferredontomembranessubsequentlyprobedwith
anti-CARMA2 antisera.
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pathways, we ﬁrst determined whether CARMA2sh and
CARMAcl can induce NF-kB activity using a luciferase
reporter assay. When CARMA2sh was expressed in
HEK-293 cells, NF-kB activity was induced at least 20- to
40-fold compared with empty vector (Fig. 3A). In
the same assay, CARMAcl was unable to promote NF-kB
activity, thus conﬁrming that the N-terminal CARD
domain of CARMA proteins is essential for NF-kB signaling
(Fig. 3A).
Fig. 3. CARMA2shinteractswithBCL10.A:HEK-293cellsweretransientlycotransfectedwithanexpressionvectorencodingfortheindicated
polypeptides,togetherwithpNF-kB-lucandpRSV-bgalreportervectors.ThetotalamountoftransfectedplasmidicDNAwasmaintainedconstant
byaddingemptyvector.Sixteenhoursaftertransfection,celllysateswerepreparedandluciferaseactivitywasmeasured.Datashownrepresent
relativeluciferaseactivitynormalizedonb-galactosidaseactivityandisrepresentativeofsixindependentexperimentsdoneintriplicate.Statistical
analysiswasbytheone-tailedunpairedStudent’st-test.B:Theindicatedexpressionvectorsweretransfectedasin(A)inHEK-293cellsexpressinga
shRNA targeting BCL10. Expression of BCL10 was monitored by immunoblot assay (bottom part). Statistical analysis was by the one-tailed
unpaired Student’s t-test. C: HEK-293 cells were transiently cotransfected with a FLAG-tagged version of CARMA2sh (left parts) or CARMA2cl
(right parts) along with HA-tagged version of wt and point mutants of BCL10, as indicated. Twenty-four hours later, cell lysates were
immunoprecipitated with anti-FLAG mAb. Immunocomplexes were separated by SDS–PAGE and transferred onto membranes subsequently
probed with anti-HA antisera.
JOURNAL OF CELLULAR PHYSIOLOGY
3124 SCUDIERO ET AL.It has been shown that CARMA3, a member of the CARMA
family of proteins, is unable to activate NF-kB in the absence of
functional BCL10 (Wang et al., 2001). To test whether also
CARMA2sh requires BCL10 for the NF-kB-inducing activity,
CARMA2sh was tested in HEK-293 cells expressing a short
hairpin RNA (shRNA) designed to target BCL10 for
degradation by the RNAi pathway. The results of these
experiments indicate that, likewise CARMA3, CARMA2sh as
well depends on functional BCL10 to induce NF-kB (Fig. 3B).
Similarly to CARMA1 and CARMA3 (Stilo et al., 2008),
activation of NF-kB mediated by CARMA2sh was inhibited by
expression of A20 (data not shown).
Biochemical data conﬁrmed our functional observation. In
fact, to verify whether CARMA2 splice variants bind to BCL10,
CARMA2sh, and CARMA2cl were co-expressed with BCL10,
cell extracts were prepared, and were immunoprecipitated
with anti-FLAG antibody. Immunoblotting experiments
revealed that CARMA2sh, but not CARMA2cl, co-
immunoprecipitated with BCL10 (Fig. 3C). The binding of
CARMA2sh to BCL10 was dependent on an intact CARD of
BCL10, because CARMA2sh failed to co-precipitate variants of
BCL10containingapointmutationL41QorG78Rthatdisrupts
CARD/CARD interactions (Srinivasula et al., 1999; Guiet and
Vito, 2000) (Fig. 3C). These results indicate that CARMA2sh,
but not CARMA2cl, associates with BCL10 through a CARD/
CARD homotypic interaction.
We next determined the cellular localization of CARMA2sh
and CARMA2cl. For this, we transfected HEK-293 cells with a
FLAG-tagged vector encoding for these splice variants of
CARMA2, and the expressed protein was detected using a
monoclonal anti-FLAG antibody. The results of these
experiments, shown in Figure 4, indicate that both CARMA2sh
and CARMA2cl exhibit a clear pattern of diffuse cytoplasmic
distribution.
Interestingly, in a set of association experiments, we also
foundthatimmunocomplexescontainingendogenousTRAF2,a
scaffold protein that transduces signals from membrane
receptors and the ER membrane (Rothe et al., 1994; Yoneda
etal.,2001;Mauroetal.,2006),alsocontainCARMA2isoforms
(Fig.5A).ToconﬁrmassociationofCARMA2shandTRAF2ina
different experimental system, a polypeptide corresponding to
Met
1-Glu
126 of CARMA2FL was expressed as His-tagged
protein in bacteria and tested for binding to TRAF2
endogenouslyexpressed.Theresultsofthesepull-downassays,
shown in Figure 5B, indicate that recombinant CARMA2 Met
1-
Glu
126 binds to TRAF2 in lysates prepared from HEK-293 and
Jurkat cells. Similar results were observed when lysates were
prepared from HeLa cell (data not shown). In addition,
coprecipitation experiments demonstrated that CARMA2sh
also binds to TRAF3, TRAF6 but not TRAF7 (Fig. 5C). To
further deﬁne the biological signiﬁcance of CARMA2sh
interaction with TRAF2, we tested the NF-kB inducing activity
Fig. 4. Subcellular localization of CARMA2 isoforms. HEK-293 (upper parts) and HeLa cells (lower parts) were transfected with mammalian
FLAG-taggedvector,empty(vector)orexpressingCARMA2shorCARMA2cl.Sixteenhoursaftertransfection,cellswerestainedwithanti-FLAG
mAb, followed by FITC-conjugated anti-mouse IgG.
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immunoprecipitatedwithanti-TRAF2antibodyoranisotype-matchedantibody.ImmunoprecipitatingmaterialwasseparatedbySDS–PAGEand
blotted onto membranes subsequently hybridized with anti-CARMA2 rabbit antiserum. B: Recombinant histidine-tagged CARMA2
1–126 was
puriﬁed with nickel–nitrilotriacetic acid-agarose beads and mixed with lysates from HEK-293 or Jurkat cells. After washing, agarose beads were
boiledinSDS-samplebuffer,separatedbySDS–PAGE,andtransferredontonitrocellulosemembraneprobedwithanti-TRAF2antibody.C:HEK-
293cellsweretransientlycotransfectedwithataggedversionofCARMA2shalongwithtaggedversionofmembersofTRAFproteins.Twenty-four
hours later, cell lysates were immunoprecipitated with anti-FLAG mAb or anti-HA antisera. Immunocomplexes were separatedby SDS–PAGE
andtransferredontomembranessubsequentlyprobedwithanti-HAantiseraoranti-FLAGmAb.D:CARMA2shfailstoactivateNF-kBinTRAF2-
deﬁcient cells wt MEFs (left columns) and TRAF2
 /  MEFs (right columns) were transfected with pNF-kB-Luc, pCMV-b-gal, and the indicated
expressionplasmids.AnexpressionvectorcodingfortheNF-kBsubunitp65servedaspositivecontrol.Cellswereharvested24haftertransfection,
andNF-kBactivitywasdetermined.Datashownrepresentsrelativeluciferaseactivitynormalizedonb-galactosidaseactivityandisrepresentative
of four independent experiments done in triplicate. Statistical analysis was by the one-tailed unpaired Student’s t-test.
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TRAF2
 /  mice and wt MEFs. As shown in Figure 5D, when
CARMA2shwasexpressedinwtMEFs,NF-kBwasinduced10-
to15-foldcomparedwithemptyvector.However,CARMA2sh
was barely able to induce NF-kB signaling in TRAF2
 /  MEFs.
Thus, a functional TRAF2 protein is required for activation of
NF-kB induced by CARMA2sh expression.
Since TRAF2 regulates apoptotic signal transduction
pathways starting from membrane receptors and the ER
membrane(Rotheetal.,1994;Yonedaetal.,2001;Mauroetal.,
2006), we investigated the involvement of CARMA2sh in cell
deathinducedbydifferentstimuli.Forthis,weestablishedHEK-
293celllinesthatstablyexpressedFLAG-taggedCARMA2shor
CARMA2cl through a lentiviral expression system and then
examined their responses to inducers of programmed cell
death. The expression of ectopic CARMA2sh or CARMA2cl
was assumed by immunoblot experiments; GFP is an irrelevant
protein and here was used as a control. As shown in
Figure 6A, expression of CARMA2sh, and partially that of
CARMA2cl, confers resistance to apoptosis induced by
thapsigargin, tunicamycin, and anisomycin treatment both in
HEK-293 cells (Fig. 6A) and HeLa cells (Fig. 6B,C). Induction of
ERstresswasmonitoredbyassessingtheexpressionlevelofER
stress marker protein BiP (Dudek et al., 2009). At a lesser
extent, CARMA2sh, but not CARMA2cl, protects cells also
from death induced by etoposide, staurosporine, and TNFa
treatment (data not shown).
To further assess the biological signiﬁcance of CARMA2 in
programmed cell death, CARMA2 expression was silenced by
siRNA. We identiﬁed a siRNA which partially silenced
CARMA2 expression in HeLa and HEK-293 cells (data not
shown). When CARMA2 expression was silenced by this
siRNA, apoptotic response was signiﬁcantly increased
compared to control siRNA (Fig. 6D). These results indicated
that increased expression of CARMA2 has a protective role in
apoptotic pathways.
Discussion
In this work, we describe the identiﬁcation and the functional
characterization of two novel isoforms of CARMA2, namely
CARMA2sh and CARMA2cl. The expression pattern of these
newly identiﬁed transcripts is, however, different. In fact, while
CARMA2shappearstobeexpressedbythevastmajorityofcell
lines analyzed, CARMA2cl appears to be expressed by few cell
types(only2outof14celllinesanalyzed).Thissuggeststhatthe
functions performed by the corresponding polypeptides might
be different, namely CARMA2sh would play a biological
function common to many cell types, whereas the function of
CARMA2cl may be more cell-type speciﬁc. In addition, the two
CARMA2 isoforms behave differently compared to
CARMA2FL. In fact, while CARMAsh, similarly to CARMA2FL,
retains the ability to activate NF-kB, CARMA2cl is unable to
positively regulate this transcription factor.
The identiﬁcation of these two alternative transcripts of
CARMA2 is particularly intriguing for several aspects regarding
the functional activity of CARMA2 and the CARMA proteins in
a broader biological context. In fact, both CARMA2cl and
CARMA2sh lack the SH3, PDZ, and GuK domains (MAGUK),
which are essential for membrane localization and lipid raft
recruitment of CARMA proteins (reviewed in Lin and Wang,
2004; Thome, 2004). This observation raises the interesting
possibility that CARMA2sh and CARMA2cl may regulate signal
transduction pathways of stimuli starting not from the cell
membrane, but rather from intracellular compartments.
Indeed, the most evident biological aspect that these two
isoforms appear to affect is apoptosis induced by thapsigargin,
tunicamycin, and anisomycin treatment. Both thapsigargin and
tunicamycin induce ER stress by inhibiting ER-resident Ca2-
ATPase, and N-glycosylation, respectively. Anisomycin is a
translational inhibitor and strongly activates the stress-
activated mitogen-activated protein (MAP) kinases pathway.
Thus, altogether these observations are consistent with the
hypothesis that these CARMA2 isoforms may regulate
intracellular signals, particularly those arising from the ER. In
this context, the ﬁnding that the functional activity of
CARMA2sh relies on TRAF2 is undoubtedly relevant, since
TRAF2 is involved in signaling from ER being able to interact
with Ire1 (Urano et al., 2000), one of the ER transmembrane
proteins involved in initiating signals from the ER. In addition,
TRAF2 mediates activation of both the JNK/SAPK and the NF-
kB pathways following ER stress (Urano et al., 2000; Leonardi
et al., 2002; Mauro et al., 2006). Therefore, we propose that
while CARMA2FL similarly to CARMA1 and CARMA3 may
transduce stimuli starting from the cell membrane, CARMAsh
and CARMAcl transduce stimuli starting from intracellular
compartments.
The mechanism through which CARMA2sh protects cells
from programmed cell death could obviously be related to the
ability of this protein to induce activation of NF-kB
transcription factor, which is well known to regulate
transcription of anti-apoptotic genes.
However,itisevidentthatotherprotectivemechanismsmay
exist, since even CARMA2cl partially protects from induced
apoptosis, although unable to activate NF-kB. Thus, one can
assume that different CARMA2 isoforms might likely impact
other functions of this protein, in addition to regulation of
apoptosis and NF-kB activation. In conclusion, our study
revealed the existence of alternative splice variants of
CARMA2, suggesting that the presence of distinct
combinations of CARMA2 splice variants might potentially
affect its biological activity. Clearly, there are many interesting
question concerning CARMA2 function that require further
investigation. In this context, the generation of animal models
genetically modiﬁed in the locus encoding for CARMA2 will be
certainly of enormous value to shed some light on the
physiological role of this protein.
Materials and Methods
Reagents
Sources of antibodies and reagents were the following: anti-FLAG,
anti-HA Sigma (St. Louis, MO); anti-TRAF2, anti-BiP, anti-cleaved
PARP Santa Cruz Biotechnology (Santa Cruz, CA); anti-BCL-10
antibody has been generated in our laboratory and has been
described elsewhere (Guiet and Vito, 2000). Thapsigargin,
tunicamycin, anisomycin, staurosporine, etoposide, and human
recombinant TNFa were obtained from Sigma. ATPLite
TM kit was
purchased from PerkinElmer Corp. (Waltham, MA) and used
according to the manufacturer’s indication.
The siRNA (Mission) directed to CARMA2 was from Sigma.
Human cDNA (Marathon-Ready-cDNA) were obtained from
Clontech (Mountain View, CA).
Cell culture and transfection
HEK293 and HeLa cells were maintained in Dulbecco’s modiﬁed
Eagle’smedium(DMEM)supplementedwith10%FBS.DNAplasmids
were transfected into cultured cells by calcium–phosphate methods
orusingLipofectamine2000(Invitrogen,Carlsbad,CA)accordingto
the manufacturer’s protocol. Jurkat cells were maintained in RPMI
medium supplemented with 10% FBS. Retroviral infections were
performed as previously described (Guiet et al., 2002).
RT-PCR
Total RNA was isolated from cells or tissues using TRIzol reagent
(Invitrogen). Expand High Fidelity PCR system (Roche, Basel,
Switzerland) was used to amplify each of the CARMA2 splice
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ALTERNATIVE SPLICING OF CARMA2/CARD14 3127Fig. 6. CARMA2sh expression protects cells from apoptosis. A: HEK-293 cells infected with a lentiviral vector expressing the indicated cDNAs
were exposed to the indicated drugs for 24h and then analyzed for apoptosis using ATPLite
TM kit analysis. Each data point represents the
meanWSDcellsurvivalexpressedaspercentageofuntreatedcellsinsixreplicates.Statisticalanalysiswasbytheone-tailedunpairedStudent’st-
test. Bottom parts: Immunoblots analysis of expressed FLAG-tagged CARMA2sh, CARMA2cl in untreated cells, and cleaved PARP or BiP upon
exposuretothedrug.B:HeLacells,stablytransfectedwithanexpressionvectorencodingfortheindicatedpolypeptides,weretreatedandanalyzed
asin(A).EachdatapointrepresentsthemeanWSDcellsurvivalexpressedaspercentageofuntreatedcellsinsixreplicates.Statisticalanalysiswas
by the one-tailed unpaired Student’s t-test. C: Phase contrast micrographs (20T) of HeLa cells stably expressing the indicated polypeptides and
exposedfor24htotheindicateddrugs.D:HeLacellsinfectedwithalentiviralvectorsexpressingashRNAstargetingCARMA2wereexposedtothe
indicateddrugsfor24h.ExtentofcelldeathwasassessedusingtheATPLite
TMkit.EachdatapointrepresentsthemeanWSDcellsurvivalexpressed
aspercentageofuntreatedcellsinsixreplicates.Statisticalanalysiswasbytheone-tailedunpairedStudent’st-test.[Colorﬁgurecanbeseeninthe
online version of this article, available at http://wileyonlinelibrary.com/journal/jcp]
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1mgoftotalRNAina20mlreactionand1mloftheresultingcDNA
wasusedinthesubsequentampliﬁcationstepalongwith300nMof
each primer. To eliminate the possibility of genomic DNA
contamination, RNA preparation was treated with RNase-free
DNase. Ampliﬁcationconsisted of42 cyclesof 958Cfor 30s, 588C
for 25s, 728C for 40s, and a ﬁnal ampliﬁcation step at 728C for
5min. The following oligos were utilized to amplify CARMA2FL:
fwd: 50-GCCTGGCTCCTGACGG-30; rev: 50-
TCGGGGGCTCTGCTCC-30. The following oligos were utilized
to amplify CARMA2sh: fwd: 50-CAAAGTGGCGACCTCGGG-30; rev: 50-
GCAATATATAAAGCATCCATCAC-30. The following oligos were utilized
to amplify CARMA2cl: fwd 50-TGTCCCGCGTTCCCAGCTG-30;
rev: 50-CTCCCGCAGCGAGTGGATG-30.
Generation of CARMA2 polyclonal antibody
A DNA fragment encoding the fragment 108–497 of CARMA2FL
was cloned into pET-28a (Novagen, San Diego, CA) to create an
N-terminal Histidine-tagged fusion protein. The His fusion protein
waspuriﬁedbyafﬁnitychromatographyonNichel–Sepharosebeads.
Cell lysate preparation and puriﬁcation of recombinant proteins
were performed as recommended by the resin manufacturer
(Sigma). The puriﬁed polypeptide was used for the immunization of
rabbits to obtain polyclonal antibodies (InCura srl, Cremona, Italy).
ATPLite assay
A total of 8 10
3 cells per well were cultured in ﬂat-bottom 96-
well plate in quadruplicates in 10% FBS/DMEM medium. Cell
viability was determined using ATPLite
TM (PerkinElmer Corp.) kit
according to the manufacturer’s instructions.
Transfections and NF-kB activation assays
4 10
4 HEK293 cells/well were plated in standard 24-well culture
dishes and transfected with the reporter constructs pRSV-b-gal
and pNF-kB-Luc plus the indicated expression plasmids using the
calcium phosphate method. The total amount of transfected
plasmid DNA was adjusted with pcDNA3 vector such that it was
constant within each individual experiment. NF-kB activation was
assessed by measuring luciferase activity (normalized for b-
galactosidase expression) in cell extracts 16h after transfection.
Wild-type (WT) and TRAF2
 /  murine embryonic ﬁbroblasts
(MEFs) were provided by Dr. T.W. Mak and Dr. W.C. Yeh (Yeh et
al., 1997). For transfections of WT and TRAF2
 /  MEFs, 4 10
4
cells/well were plated in 24-well culture 24h prior to transfection.
Expression and reporter plasmids were transfected using the
Attractene(Qiagen,Milano,Italy).Thecellswerelysedandassayed
24h after transfection using the luciferase assay system (Promega,
Madison, WI) according to the manufacturer’s instructions.
Fig. 6. (Continued)
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1 10
4 HEK293 or HeLa cells were grown and transfected in
chamberslides.Sixteenhoursaftertransfection,cellswereﬁxedin
4% paraformaldehyde for 15min at room temperature and then
permeabilized in PBS/0.1% Triton X-100. Cells were incubated for
30min in 5% FCS–PBS with primary antibodies were, followed by
several washes with 5% FCS–PBS, and then incubating for 30min
with secondary antibody in 5% FCS–PBS. All steps were done at
room temperature.
Immunoblot analysis and coprecipitation
Celllysatesweremadeinlysisbuffer(150mMNaCl,20mMHepes,
pH 7.4, 1% Triton X-100, 10% glycerol, and a mixture of protease
inhibitors). Proteins were separated by SDS–PAGE, transferred
onto nitrocellulose membrane, and incubated with primary
antibodies followed by horseradish peroxidase-conjugated
secondary antibodies (Amersham Biosciences, Piscataway, NJ).
Blots were developed using the ECL system (Amersham
Biosciences).Forco-immunoprecipitationexperiments,cellswere
lysed in lysis buffer and immunocomplexes were bound to protein
A/G, resolved by SDS–PAGE, and analyzed by immunoblot assay.
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